MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, VNDA made $216,105K in revenue. -$220,474K in net income. Net profit margin of -102.02%.

Income Overview

Revenue
$216,105K
Net Income
-$220,474K
Net Profit Margin
-102.02%
EPS
-$3.74
Unit: Thousand (K) dollars
Revenue Breakdown
    • Fanapt
    • Hetlioz
    • PONVORY

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-12-31
Total revenues
216,105
Cost of goods sold excluding amortization
13,044
Research and development
109,271
Selling, general and administrative
237,951
Intangible asset amortization
7,007
Total operating expenses
367,273
Loss from operations
-151,168
Other income, net
12,521
Income (loss) before income taxes
-138,647
Provision (benefit) for income taxes
81,827
Net income (loss)
-220,474
Basic (in dollars per share)
-3.74
Basic (in shares)
58,930,157
Diluted (in dollars per share)
-3.74
Diluted (in shares)
58,930,157
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net income (loss)-$220,474K PONVORY$27,372K Hetlioz$71,431K Fanapt$117,302K Provision (benefit) forincome taxes$81,827K Income (loss) beforeincome taxes-$138,647K Other income, net$12,521K Net product sales$216,105K Loss from operations-$151,168K Total revenues$216,105K Total operatingexpenses$367,273K Intangible assetamortization$7,007K Selling, general andadministrative$237,951K Research and development$109,271K Cost of goods soldexcluding amortization$13,044K

Vanda Pharmaceuticals Inc. (VNDA)

Vanda Pharmaceuticals Inc. (VNDA)